Stock DNA
Pharmaceuticals: Major
CAD 75 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
3.35
770.98%
-34.86
Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Mar 2023)
Net Profit:
-3 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
48.0%
0%
48.0%
6 Months
155.17%
0%
155.17%
1 Year
68.18%
0%
68.18%
2 Years
2.78%
0%
2.78%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Mindset Pharma, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
-16.58
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
3.35
Sales to Capital Employed (avg)
-0.07
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-34.86
EV to EBIT
-4.09
EV to EBITDA
-4.10
EV to Capital Employed
-7.24
EV to Sales
17.35
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'23 - QoQ
Mar'23
Dec'22
Change(%)
Net Sales
1.90
2.50
-24.00%
Operating Profit (PBDIT) excl Other Income
-2.90
-2.10
-38.10%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.90
-2.10
-38.10%
Operating Profit Margin (Excl OI)
-1,559.80%
-835.30%
-72.45%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2023 is -24.00% vs 47.06% in Dec 2022
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2023 is -38.10% vs -320.00% in Dec 2022
Annual Results Snapshot (Consolidated) - Jun'22
Jun'22
Jun'21
Change(%)
Net Sales
3.90
0.00
Operating Profit (PBDIT) excl Other Income
-16.50
-8.40
-96.43%
Interest
0.00
0.00
Exceptional Items
-0.00
-3.20
100.00%
Consolidate Net Profit
-16.60
-11.70
-41.88%
Operating Profit Margin (Excl OI)
-4,244.30%
0.00%
-424.43%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2022 is 0.00% vs 0.00% in Jun 2021
Consolidated Net Profit
YoY Growth in year ended Jun 2022 is -41.88% vs -2,240.00% in Jun 2021






